Patents Assigned to TECHNOLOGIES BIOLACTIS INC.
  • Publication number: 20140328878
    Abstract: The present invention relates to a malleable protein matrix (MPM), which is the reaction product of the agglomeration of proteins after a fermentation process and is exhibiting biological activities and is suitable for the incorporation (or encapsulation) of various hydrophilic or lipophylic substances. The present invention also relates to the process for the preparation of the malleable protein matrix and its usages.
    Type: Application
    Filed: January 8, 2014
    Publication date: November 6, 2014
    Applicant: Technologies Biolactis Inc.
    Inventors: Eric Simard, Dominique Pilote, Claude DuPont, Nathalie Lajoie, Marcel Paquet, Pierre Lemieux, Philippe Goyette
  • Publication number: 20140193383
    Abstract: In accordance with the present invention, there is provided a probiotic composition comprising an effective amount of Lactobacillus kefiranofaciens in association with a suitable carrier. The probiotic composition has many probiotic effects such as intestinal adherence, intestinal persistence, positive modulation of the intestinal microflora, protection against intestinal pathogens, immunomodulation, protection against systemic inflammation, protection against intestinal inflammation, protection against allergies, protection against diarrhea, protection against diabetes, protection against hyperlipidemia and protection against colon cancer. In accordance with the present invention, there is also provided a method of treatment and/or prevention of a number of diseases for which the composition has a beneficial effect.
    Type: Application
    Filed: August 21, 2013
    Publication date: July 10, 2014
    Applicant: Technologies Biolactis Inc.
    Inventors: Pierre Lemieux, Louis Phillippe Precourt, Eric Simard
  • Publication number: 20100272676
    Abstract: The present invention relates to an anti-cancer vaccine composition comprising an antigen in association with an effective amount of at least one immunomodulator chemotherapeutic adjuvant eliciting an immune response in a patient and a pharmaceutically acceptable carrier. It also relates to method of preventing tumor growth and reducing tumor growth using the anti-cancer vaccine composition of the present invention.
    Type: Application
    Filed: April 2, 2010
    Publication date: October 28, 2010
    Applicant: TECHNOLOGIES BIOLACTIS INC.
    Inventors: Éric Simard, Philippe Goyette, Pierre Lemieux